bronchiol
diseas
condit
character
trap
air
lung
difficulti
expir
ie
wheez
caus
inflamm
infect
bronchiol
smallest
highestresist
airway
croup
diseas
condit
character
difficulti
inspir
associ
barki
cough
caus
respiratori
viru
infect
human
common
frequent
infect
man
hundr
differ
virus
consid
respiratori
virus
virus
enter
respiratori
tract
includ
virus
replic
caus
diseas
restrict
respiratori
epithelium
virus
enter
mucosa
also
spread
viremia
caus
system
diseas
exampl
latter
measl
viru
sar
coronaviru
anoth
gener
virus
caus
viremia
capabl
reinfect
host
multipl
time
throughout
life
contrast
infect
system
virus
sometim
induc
lifelong
immun
diseas
probabl
high
rate
reinfect
mucos
restrict
virus
reflect
difficulti
metabol
cost
maintain
high
level
immun
vast
surfac
area
mucosa
virusspecif
iga
level
maintain
high
level
gener
sever
week
month
infect
anatomi
cell
type
respiratori
tract
dictat
larg
degre
type
diseas
observ
respiratori
viru
infect
demarc
upper
lower
respiratori
tract
vocal
cord
structur
upper
respiratori
tract
interconnect
includ
nasopharynx
larynx
eustachian
tube
middl
ear
space
sinus
signific
collect
lymphoid
tissu
resid
upper
respiratori
tract
tonsil
adenoid
lower
respiratori
tract
structur
includ
trachea
bronchi
bronchiol
alveoli
lung
tissu
cell
type
line
respiratori
tract
complex
exhibit
differ
suscept
viru
infect
predomin
cell
type
ciliat
noncili
epitheli
cell
goblet
cell
clara
cell
smooth
muscl
cell
promin
featur
airway
level
bronchiol
lung
possess
type
ii
pneumocyt
patholog
process
wheez
driven
mostli
level
bronchiol
smooth
muscl
contract
obstruct
caus
mucou
accumul
epitheli
slough
pneumonia
infect
pneumocyt
deeper
tissu
diseas
syndrom
associ
respiratori
virus
gener
follow
anatomi
respiratori
tract
differ
virus
appear
tropism
differ
cell
region
respiratori
tract
therefor
particular
associ
virus
clinic
syndrom
clinic
diagnos
infect
diseas
manifest
respiratori
tract
rhiniti
common
cold
sinus
otiti
media
conjunct
pharyng
laryng
tracheiti
acut
bronchiti
bronchiol
pneumonia
exacerb
reactiv
airway
diseas
asthma
clinic
syndrom
system
ill
due
respiratori
virus
includ
influenza
syndrom
measl
sever
acut
respiratori
syndrom
sar
hantaviru
pulmonari
syndrom
hp
princip
caus
acut
viral
respiratori
infect
children
becam
appar
larg
epidemiolog
studi
conduct
soon
cell
cultur
techniqu
becam
avail
landmark
studi
associ
virus
clinic
syndrom
perform
recent
studi
increas
understand
caus
viral
respiratori
infect
infant
especi
advent
molecular
test
revers
transcript
combin
polymeras
chain
reaction
rtpcr
sensit
cell
cultur
respiratori
syncyti
viru
rsv
parainfluenza
virus
piv
adenovirus
influenza
virus
identifi
initi
common
caus
seriou
lower
respiratori
tract
diseas
infant
children
recent
human
metapneumoviru
hmpv
identifi
major
caus
seriou
ill
last
year
number
addit
virus
associ
respiratori
ill
discuss
howev
infecti
agent
still
identifi
clinic
ill
larg
surveil
studi
even
use
sensit
diagnost
techniqu
viral
cultur
multipl
cell
line
antigen
detect
assay
rtpcr
base
method
known
ill
due
identifi
pathogen
simpli
detect
due
low
titer
viru
patient
sampl
novel
agent
yet
identifi
reactiv
latent
virus
herpesvirus
hsv
cmv
adenovirus
occur
immunocompromis
human
particularli
subject
latestag
hiv
infect
organ
transplant
patient
leukopenia
neutropenia
caus
chemotherapi
cmv
frequent
recov
viru
diagnost
procedur
bronchoalveolar
lavag
immunosuppress
patient
pneumonia
patient
also
suffer
frequent
sever
diseas
includ
mortal
common
respiratori
virus
includ
rsv
hmpv
piv
influenza
virus
rhinovirus
adenovirus
nosocomi
transmiss
includ
larg
unit
outbreak
uncommon
result
high
frequenc
transmiss
picornavirida
wide
varieti
picornavirus
caus
respiratori
diseas
includ
rhinovirus
enterovirus
includ
coxsackievirus
ab
echovirus
nonpolio
enterovirus
parechovirus
enteroviru
infect
occur
commonli
summer
month
temper
area
differ
season
mani
common
respiratori
virus
paramyxovirus
influenza
viru
rhinoviru
infect
occur
yearround
rhinoviru
genu
famili
picornavirida
virus
rhinovirus
common
viral
infect
agent
human
caus
agent
common
cold
serolog
viru
type
also
classifi
larg
number
genotyp
caus
cold
symptom
speci
rhinoviru
contain
type
speci
rhinoviru
b
type
speci
rhinoviru
c
type
rhinovirus
respons
half
case
common
cold
rhinovirus
singlestrand
positivesens
rna
genom
viral
particl
icosahedr
structur
nonenvelop
rhinovirusinduc
common
cold
may
complic
children
otiti
media
adult
sinus
adult
fact
radiograph
evid
sinus
common
cold
resolv
without
therapi
therefor
primari
diseas
probabl
best
term
rhinosinus
rhinoviru
infect
associ
exacerb
reactiv
airway
diseas
children
asthma
adult
clear
whether
rhinoviru
restrict
upper
respiratori
tract
induc
inflammatori
respons
affect
lower
respiratori
tract
indirectli
whether
virus
spread
lower
respiratori
tract
past
thought
virus
often
replic
caus
diseas
lower
respiratori
tract
howev
recent
studi
discern
strong
epidemiolog
associ
rv
wheez
asthma
exacerb
includ
episod
sever
enough
requir
hospit
like
rhinovirus
infect
lower
airway
degre
induc
local
inflammatori
respons
anoth
possibl
signific
local
infect
upper
respiratori
tract
might
induc
region
elabor
mediat
caus
lower
airway
diseas
associ
rhinoviru
infect
lower
respiratori
tract
ill
difficult
studi
diagnosi
cell
cultur
sensit
rtpcr
diagnost
test
difficult
interpret
often
posit
prolong
period
time
even
asymptomat
individu
may
posit
test
comprehens
serolog
confirm
infect
difficult
larg
number
serotyp
nevertheless
expert
believ
rhinovirus
common
caus
seriou
lower
respiratori
tract
ill
virus
caus
oral
lesion
often
associ
children
diseas
syndrom
term
handfootandmouth
diseas
pharyng
associ
infect
often
mark
characterist
find
herpangina
clinic
syndrom
ulcer
small
vesicl
palat
often
involv
tonsillar
fossa
associ
symptom
fever
difficulti
swallow
throat
pain
outbreak
commonli
occur
young
children
summer
nonpolio
enterovirus
common
distribut
worldwid
although
infect
often
asymptomat
virus
caus
outbreak
clinic
respiratori
diseas
sometim
fatal
consequ
studi
associ
particular
type
clinic
syndrom
enteroviru
wheez
enteroviru
pneumonia
term
echo
name
viru
acronym
enter
cytopath
human
orphan
although
may
archaic
notion
sinc
echovirus
associ
human
diseas
commonli
children
least
echoviru
serotyp
echovirus
isol
mani
children
upper
respiratori
tract
infect
summer
month
echoviru
associ
laryngotrach
croup
epidemiolog
studi
also
associ
echovirus
epidem
pleurodynia
acut
ill
character
sharp
chest
pain
fever
virus
compris
six
type
genotyp
assign
new
genu
famili
picornavirida
distinct
laboratorybas
molecular
properti
common
member
genu
parechoviru
human
parechoviru
formerli
echoviru
frequent
human
pathogen
genu
also
includ
close
relat
viru
human
parechoviru
formerli
echoviru
human
parechovirus
usual
caus
mild
respiratori
gastrointestin
ill
infect
occur
young
children
high
seropreval
parechovirus
adult
descript
neonat
case
sever
diseas
rsv
singlestrand
negativesens
nonseg
rna
genom
viru
famili
paramyxovirida
genu
pneumoviru
one
infecti
virus
human
infect
infant
young
age
often
first
week
month
life
common
viral
caus
sever
lower
respiratori
tract
ill
children
one
import
caus
hospit
infant
children
throughout
world
one
serotyp
circul
virus
exhibit
antigen
dimorph
two
antigen
subgroup
design
b
reciproc
crossneutr
studi
use
human
sera
show
antigen
group
relat
reinfect
common
caus
virus
subgroup
yearli
epidem
diseas
often
peak
decemb
march
temper
region
rsv
infect
caus
mild
upper
respiratori
tract
infect
infant
young
children
result
hospit
infant
due
wheez
pneumonia
children
infect
age
year
associ
rsv
infect
earli
life
subsequ
asthma
although
causal
relationship
controversi
hospit
infant
otherwis
healthi
prior
infect
group
consid
high
risk
sever
diseas
prematur
infant
especi
chronic
lung
diseas
infant
born
congenit
heart
diseas
immunocompromis
patient
age
risk
sever
diseas
sever
diseas
also
common
elderli
especi
institution
frail
elderli
virus
constitut
group
four
distinct
serotyp
type
singlestrand
rna
virus
belong
famili
paramyxovirida
consid
group
second
common
caus
lower
respiratori
tract
infect
young
children
common
caus
sever
diseas
repeat
infect
throughout
life
common
first
infect
commonli
associ
lower
respiratori
tract
diseas
especi
laryngotrach
croup
subsequ
infect
typic
limit
upper
respiratori
tract
piv
detect
use
cell
cultur
hemadsorpt
immunofluoresc
microscopi
rtpcr
investig
netherland
describ
new
human
respiratori
viru
hmpv
evid
near
univers
seroconvers
found
gener
popul
year
age
suggest
ubiquit
infect
earli
childhood
viru
member
genu
pneumoviru
rsv
differ
rsv
lack
nonstructur
gene
counteract
host
interferon
possess
slightli
differ
gene
order
studi
role
hmpv
pediatr
lower
respiratori
tract
infect
lri
otherwis
healthi
children
unit
state
use
prospect
collect
databas
sampl
archiv
repres
children
reveal
nearli
lri
children
associ
posit
hmpv
test
similar
studi
suggest
viru
one
major
respiratori
pathogen
earli
childhood
clinic
featur
hmpv
lri
similar
paramyxovirus
often
result
cough
coryza
syndrom
bronchiol
croup
interestingli
hmpv
seem
clinic
intermedi
rsv
piv
tend
caus
bronchiol
similar
frequenc
rsv
frequent
piv
caus
croup
less
often
latter
studi
subject
condit
predispos
increas
risk
respiratori
ill
suggest
hmpv
play
signific
role
exacerb
asthma
children
adult
lri
immunocompromis
subject
frail
elderli
measl
viru
paramyxoviru
genu
morbilliviru
caus
infect
system
diseas
also
known
rubeola
viru
spread
direct
contactfomit
transmiss
aerosol
transmiss
therefor
one
highli
contagi
infect
man
classic
symptom
measl
includ
day
fever
often
quit
high
clinic
constel
symptom
term
three
cs
cough
coryza
conjunct
characterist
dissemin
maculopapular
rash
appear
soon
onset
fever
transient
mucos
lesion
mouth
characterist
appear
koplik
spot
consid
diagnost
identifi
experienc
clinician
viru
caus
number
system
effect
complic
sever
pneumonia
especi
primari
infect
occur
unvaccin
adult
immunocompromis
person
age
mortal
develop
countri
high
especi
infect
occur
set
malnutrit
emerg
pathogen
group
new
genu
henipavirus
may
respiratori
pathogen
convent
sens
paramyxovirus
probabl
infect
human
respiratori
rout
nipah
viru
newli
recogn
zoonot
viru
name
locat
malaysia
first
identifi
caus
diseas
human
contact
infecti
anim
hendra
viru
formerli
call
equin
morbilliviru
anoth
close
relat
zoonot
paramyxoviru
first
isol
australia
virus
caus
local
outbreak
wide
host
rang
abil
caus
high
mortal
rais
concern
futur
natur
host
virus
thought
certain
speci
fruit
bat
present
australia
pacif
pig
may
intermedi
host
transmiss
human
nipah
infect
hors
case
hendra
although
mode
transmiss
anim
human
defin
like
inocul
infect
materi
onto
respiratori
tract
play
role
clinic
present
usual
appear
influenzalik
syndrom
progress
enceph
may
includ
respiratori
ill
caus
death
half
identifi
case
influenza
singlestrand
segment
negativesens
rna
genom
viru
famili
orthomyxovirida
three
type
influenza
virus
influenza
viru
influenza
viru
b
influenza
viru
c
influenza
c
infect
multipl
speci
influenza
b
infect
human
almost
exclus
type
virus
virul
human
pathogen
among
three
influenza
type
caus
sever
diseas
influenza
viru
subdivid
differ
subtyp
base
antibodi
respons
virus
subtyp
confirm
human
season
influenza
order
number
known
human
pandem
death
caus
pandem
caus
pandem
avian
influenza
origin
china
caus
pandem
current
b
virus
caus
annual
season
epidem
addit
viru
infect
human
occur
epizoot
influenza
hong
kong
poultri
popul
diseas
affect
anim
mani
speci
exhibit
high
rate
mortal
human
viru
spread
throughout
asia
beyond
carri
wild
bird
humantohuman
transmiss
occur
effici
time
howev
widespread
current
concern
potenti
pandem
viru
acquir
transmiss
among
human
avian
viru
also
unusu
zoonot
potenti
viru
caus
outbreak
human
netherland
associ
outbreak
commerci
poultri
sever
farm
one
death
occur
peopl
confirm
influenza
viru
infect
signific
outbreak
viru
began
china
march
high
mortal
viru
appear
endem
pig
human
variant
viru
endem
pig
sporad
infect
human
close
contact
state
fair
us
human
infect
report
influenza
b
viru
almost
exclus
human
pathogen
less
common
influenza
mutat
less
rapidli
influenza
one
influenza
b
subtyp
although
current
two
major
lineag
exhibit
antigen
differer
fujianlik
virus
bshanghailik
strain
human
common
symptom
influenza
infect
syndrom
fever
sore
throat
myalgia
headach
cough
fatigu
seriou
case
influenza
caus
pneumonia
fatal
particularli
young
children
elderli
influenza
pneumonia
unusu
high
rate
complic
bacteri
superinfect
staphylococc
streptococc
bacteri
pneumonia
occur
mani
case
clinic
seri
virus
famili
adenovirida
infect
human
anim
adenovirus
first
isol
human
lymphoid
tissu
surgic
remov
adenoid
henc
name
viru
fact
serotyp
establish
persist
asymptomat
infect
tonsil
adenoid
tissu
viru
shed
occur
month
year
doublestrand
dna
virus
less
nm
size
nonenvelop
icosahedr
morpholog
larg
dsdna
genom
linear
nonseg
seven
major
human
adenoviru
speci
design
g
place
immunolog
distinct
serotyp
human
respiratori
tract
infect
mainli
caus
b
c
speci
adenoviru
infect
occur
throughout
year
sporad
outbreak
occur
mani
serotyp
other
appear
endem
particular
locat
respiratori
ill
includ
mild
diseas
common
cold
lower
respiratori
tract
ill
includ
croup
bronchiol
pneumonia
conjunct
associ
infect
speci
b
particular
constel
symptom
call
pharyngoconjunctiv
fever
frequent
associ
acut
adenoviru
infect
contrast
gastroenter
associ
frequent
serotyp
viru
speci
f
immunocompromis
subject
highli
suscept
sever
diseas
infect
respiratori
adenovirus
syndrom
acut
respiratori
diseas
ard
especi
common
stress
crowd
live
condit
first
recogn
among
militari
recruit
world
war
ii
continu
problem
militari
follow
suspens
vaccin
ard
often
associ
adenoviru
type
member
genu
coronaviru
also
contribut
respiratori
ill
includ
sever
diseas
dozen
coronavirus
affect
anim
twentieth
centuri
two
repres
strain
human
coronavirus
known
caus
diseas
human
coronaviru
outbreak
sarsassoci
coronaviru
sarscov
show
anim
coronavirus
potenti
cross
speci
human
devast
effect
one
major
epidem
date
novemb
juli
case
diseas
mortal
rate
approach
sarscov
caus
system
ill
respiratori
rout
entri
sar
uniqu
form
viral
pneumonia
contrast
viral
pneumonia
upper
respiratori
symptom
usual
absent
sar
although
cough
dyspnea
occur
patient
typic
patient
present
nonspecif
ill
manifest
fever
myalgia
malais
chill
rigor
wateri
diarrhea
may
occur
well
investig
report
identif
fourth
human
coronaviru
new
group
coronaviru
evid
emerg
common
respiratori
pathogen
human
caus
upper
lower
respiratori
tract
ill
human
coronaviru
hcov
first
describ
januari
follow
detect
patient
pneumonia
sever
case
respiratori
ill
associ
viru
infrequ
identif
suggest
date
put
group
coronaviru
caus
low
incid
ill
middl
east
respiratori
syndrom
coronaviru
merscov
first
isol
caus
sever
diseas
human
viru
may
emerg
bat
middl
east
camel
like
intermedi
host
sever
herp
virus
caus
upper
respiratori
infect
especi
infect
oral
caviti
herp
simplex
pharyng
associ
characterist
clinic
find
acut
ulcer
stomat
ulcer
pharyng
herp
simplex
viru
herp
simplex
viru
also
call
human
herpesviru
human
herpesviru
respect
caus
oral
lesion
although
oral
infect
caus
primari
oral
diseas
sever
especi
young
children
sometim
admit
rehydr
therapi
due
poor
oral
intak
signific
proport
individu
suffer
recurr
symptomat
diseas
consist
vesicl
lip
epsteinbarr
viru
ebv
mononucleosi
syndrom
often
mark
acut
subacut
exud
pharyng
case
swell
tonsil
ebv
pharyng
sever
airway
occlus
appear
immin
virus
famili
herpesvirida
caus
sever
diseas
immunocompromis
patient
especi
hematopoiet
stem
cell
transplant
patient
includ
cytomegaloviru
cmv
ebv
varicellazost
viru
herpesviru
herpesviru
herpesviru
new
viru
identifi
recent
respiratori
sampl
children
lower
respiratori
tract
diseas
sweden
sequenc
analysi
viral
genom
reveal
viru
highli
relat
canin
minut
viru
bovin
parvoviru
member
genu
bocaviru
subfamili
parvovirina
famili
parvovirida
viru
tent
name
human
bocaviru
hbov
hbov
identifi
sole
agent
limit
number
respiratori
sampl
children
hospit
respiratori
tract
diseas
still
controversi
whether
viru
caus
mere
associ
diseas
preliminari
studi
case
hp
report
unit
state
diseas
first
recogn
outbreak
third
recogn
case
end
death
four
corner
area
outbreak
well
known
howev
case
report
state
patient
hp
usual
present
febril
ill
begin
symptom
flulik
ill
physic
examin
specif
often
find
fever
increas
heart
respiratori
rate
addit
respiratori
symptom
abdomin
pain
fever
common
diagnosi
often
delay
sever
ill
occur
requir
mechan
ventil
rotavirus
dsrna
enter
virus
common
caus
sever
viral
infecti
gastroenter
children
clinic
seri
suggest
children
gastroenter
suffer
upper
respiratori
symptom
prodrom
diseas
manifest
viru
recov
respiratori
secret
report
suggest
rotaviru
infect
associ
lower
respiratori
tract
ill
although
associ
unclear
dsrna
virus
name
use
acronym
respiratori
enter
orphan
viru
clearli
associ
respiratori
diseas
seroconvers
rate
high
first
year
life
probabl
caus
minor
subclin
ill
pharyng
occur
primari
hiv
infect
may
associ
mucos
eros
lymphadenopathi
polyomavirus
small
dsdna
genom
nonenvelop
icosahedr
virus
may
oncogen
two
major
polyomavirus
known
infect
human
jc
bk
virus
eighti
percent
adult
us
subject
seroposit
virus
jc
viru
infect
respiratori
system
kidney
brain
bk
viru
infect
caus
mild
respiratori
infect
pneumonia
involv
kidney
immunosuppress
transplant
patient
given
overlap
winter
season
virus
temper
area
surpris
coinfect
two
virus
occur
gener
care
studi
use
cell
cultur
techniqu
use
viru
isol
one
viru
isol
respiratori
secret
otherwis
healthi
subject
acut
respiratori
ill
case
adult
children
littl
evid
sever
diseas
occur
coinfect
although
insuffici
evid
point
definit
incid
two
molecular
diagnost
test
posit
gener
rtpcr
rna
virus
expect
higher
cultur
molecular
test
remain
posit
extend
period
time
viru
shed
end
respiratori
virus
gener
two
main
mode
transmiss
larg
particl
aerosol
respiratori
droplet
transmit
directli
persontoperson
cough
sneez
fomit
fomit
transmiss
occur
indirectli
infect
respiratori
droplet
deposit
hand
inanim
object
surfac
subsequ
transfer
secret
suscept
subject
nose
conjunctiva
respiratori
virus
unlik
measl
viru
varicella
zoster
viru
spread
small
particl
aerosol
across
room
hall
therefor
contact
droplet
precaut
suffici
prevent
transmiss
set
handwash
critic
healthcar
set
winter
season
ribavirin
nucleosid
antimetabolit
prodrug
activ
kinas
cell
result
triphosph
nucleotid
form
inhibit
rna
replic
drug
licens
aerosol
form
us
treatment
children
sever
rsv
lower
respiratori
tract
infect
efficaci
aerosol
ribavirin
therapi
remain
uncertain
despit
number
clinic
trial
center
use
infrequ
ever
otherwis
healthi
infant
sever
rsv
diseas
intraven
ribavirin
use
adenoviru
hantaviru
measl
viru
piv
influenza
viru
infect
although
good
riskbenefit
profil
establish
clearli
use
human
mous
monoclon
antibodi
direct
f
protein
rsv
palivizumab
licens
prevent
rsv
hospit
highrisk
infant
efficaci
half
highrisk
subject
experiment
treatment
immunocompet
immunocompromis
rsvinfect
subject
report
efficaci
approach
establish
four
licens
drug
us
treatment
prophylaxi
influenza
amantadin
rimantadin
two
drug
interfer
ion
channel
activ
caus
viral
protein
influenza
virus
need
viral
particl
uncoat
follow
endocytosi
two
drug
oseltamivir
zanamivir
neuraminidas
inhibitor
act
influenza
b
virus
serv
transit
state
analog
viral
neuraminidas
need
releas
newli
bud
virion
progeni
surfac
infect
cell
cell
surfac
normal
coat
heavili
viral
receptor
sialic
acid
resist
ion
channel
inhibitor
aris
rapidli
prophylaxi
treatment
resist
level
becam
common
circul
virus
cdc
longer
recommend
use
drug
interferona
shown
protect
rhinoviru
infect
use
intranas
biolog
drug
caus
side
effect
nasal
bleed
resist
drug
develop
experiment
use
molecul
longer
develop
purpos
pleconaril
test
treatment
rhinoviru
infect
oral
drug
good
bioavail
treat
infect
caus
picornavirus
drug
act
bind
hydrophob
pocket
protein
stabil
protein
capsid
prevent
releas
viral
rna
cell
drug
reduc
mucu
secret
symptom
examin
acyclovir
relat
compound
guanin
analog
antivir
drug
use
treatment
herp
viru
infect
hsv
stomat
immunocompromis
patient
treat
famciclovir
valacyclovir
immunocompet
subject
sever
oral
diseas
compromis
oral
intak
sometim
treat
compound
also
use
prophylact
prevent
recurr
outbreak
mix
result
intraven
acyclovir
effect
hsv
varicella
zoster
viru
pneumonia
immunocompromis
subject
ganciclovir
human
immunoglobulin
may
reduc
mortal
associ
cmv
pneumonia
hematopoiet
stem
cell
transplant
recipi
use
monotherapi
patient
group
cidofivir
nucleotid
analog
activ
larg
number
virus
includ
adenovirus
intraven
cidofovir
effect
manag
sever
adenovir
infect
immunocompromis
patient
may
caus
seriou
nephrotox
licens
vaccin
influenza
virus
us
trival
quadrival
one
two
b
antigen
inactiv
intramuscular
vaccin
live
attenu
trival
vaccin
intranas
administr
avail
efficaci
vaccin
good
vaccin
strain
chosen
highli
relat
antigen
epidem
strain
antigen
drift
caus
point
mutat
ha
na
molecul
lead
antigen
diverg
requir
new
vaccin
made
year
influenza
genom
segment
allow
reassort
two
virus
occur
coinfect
sometim
lead
major
antigen
shift
result
pandem
pandem
occur
everi
year
averag
current
concern
potenti
pandem
experiment
vaccin
test
virus
date
vaccin
poorli
immunogen
compar
compar
season
influenza
vaccin
adjuv
improv
immunogen
vaccin
develop
adenoviru
serotyp
approv
prevent
epidem
respiratori
ill
among
militari
recruit
essenti
unmodifi
virus
given
enter
rout
capsul
instead
respiratori
rout
natur
rout
infect
lead
diseas
inocul
alter
rout
result
immun
asymptomat
infect
us
militari
recruit
vaccin
adenoviru
near
complet
prevent
diseas
popul
sole
manufactur
vaccin
halt
product
suppli
ran
year
later
sinc
adenoviru
infect
reemerg
signific
problem
militari
approxim
recruit
suffer
ill
due
adenoviru
infect
basic
train
death
occur
live
attenu
vaccin
candid
develop
test
phase
ii
clinic
trial
rsv
piv
mutant
strain
reduc
pathogen
isol
laboratori
test
sequenc
vaccin
candid
optim
combin
mutat
separ
biolog
deriv
virus
singl
strain
use
recombin
techniqu
gener
rna
virus
cdna
copi
process
call
revers
genet
subunit
vaccin
develop
rsv
safeti
concern
use
young
infant
formalin
inactiv
vaccin
induc
sever
diseas
respons
infect
subunit
rsv
vaccin
like
test
set
matern
immun
shortli
vaccin
rhinovirus
littl
crossprotect
serotyp
feasibl
develop
vaccin
serotyp
effort
develop
coronaviru
vaccin
preclin
stage
